Lemon balm
Also called Melissa officinalis, melissa, balm, bee balm. Botanical (leaf of Melissa officinalis; traditional herbal medicine and food flavoring).
Bottom line
Lemon balm is the leaf of Melissa officinalis, used as a traditional herbal medicine for mild stress and sleep [24]. Small single-dose trials, mostly from one research group, found more calmness at some doses but not others, and a larger trial found no change in overall calmness [1][2][3][5]. LiverTox rates it an unlikely cause of clinically apparent liver injury [22].
- In placebo-controlled crossover trials of 18 to 20 healthy volunteers, mostly young adults, single doses of lemon balm raised self-rated calmness at one dose in each trial, but the effective dose differed between trials [1][2][3].
- In a parallel-group trial of 106 young adults with moderate stress complaints, funded by the ingredient supplier Givaudan France Naturals, 300 mg of a lemon balm extract did not change overall calmness, the primary outcome [5].
- Single-dose trials found both better and worse scores on memory and attention tasks, depending on dose and test [1][2].
- In a meta-analysis of trials in people with symptoms of anxiety or depression, lemon balm lowered symptom scores compared with placebo, with high heterogeneity between studies [7].
- The European Medicines Agency lists no known side effects, and LiverTox rates lemon balm an unlikely cause of clinically apparent liver injury [24][22].
Evidence by outcome
| Outcome | Grade | Basis | Modifiers | Rationale |
|---|---|---|---|---|
| Mood | C Limited | Meta-analysis pooling symptomatic and clinical populations with high heterogeneity, plus one RCT (n = 100) in healthy adults with distress whose product was donated by the supplier and whose abstract reports within-trial improvement without a placebo comparison | Short-term onlySubjective outcome only | Why C grade for Mood: explainedApproved of the Mood grade |
| Sleep quality | C Limited | Small, short RCTs leaning toward benefit; two of three positive controlled trials industry-linked; one clinical trial null | Short-term onlyIndustry-funded | Why C grade for Sleep quality: explainedApproved of the Sleep quality grade |
| Acute cognitive performance | C Limited, no effect found | Small acute crossover trials from one research group with improvements and decrements by dose and task | Short-term onlySingle research group | Why C grade for Acute cognitive performance: explainedApproved of the Acute cognitive performance grade |
| Global cognition | C Limited, no effect found | Older-adult and clinical evidence only; one adequately sized RCT null on its primary outcome is not enough for N | Why C grade for Global cognition: explainedApproved of the Global cognition grade | |
| Calmness | C Limited, no effect found | Small acute crossover trials from one research group with dose-inconsistent positives, plus one larger parallel trial null on calmness as its primary outcome | Short-term onlySubjective outcome onlySingle research group | Why C grade for Calmness: explainedApproved of the Calmness grade |
Grades describe evidence for each outcome, not a recommendation. Open a grade for its rationale and dated grade history. How we grade
Most single-dose trials of lemon balm in healthy adults came from one research group: DO Kennedy and AB Scholey are authors on three of them, and Scholey led a fourth [1][2][3][4]. Longer trials mostly enrolled people with symptoms or a diagnosis; each section names the population. Results in clinical groups may not apply to healthy adults. Our grades are proposals per outcome; the evidence grading method explains what each grade requires.
Does lemon balm make people feel calmer?
The evidence is mixed. Calmness here means a self-rating on the Bond-Lader mood scales, measured over hours after a single dose [1][2].
In a 2002 double-blind crossover trial, 20 healthy young adults took 300, 600 and 900 mg of a standardized extract (Pharmaton) or placebo, a week apart [1]. Calmness rose at the earliest time points after the lowest dose, while alertness fell at all time points after the highest dose [1]. In a 2003 trial of the same design with encapsulated dried leaf at 600, 1000 and 1600 mg, calmness rose at all time points after the highest dose [2]. In a 2004 crossover trial of 18 healthy volunteers given a laboratory stress task, 600 mg increased calmness and reduced alertness [3].
A later, larger trial from another group found no effect on its main measure [5]. In 106 young healthy adults with moderate stress complaints, 300 mg of the Zensera extract did not change overall calmness, the primary outcome, compared with placebo [5]. Feelings of calmness did recover after demanding test sessions with the extract, which was not seen with placebo [5]. The study was funded by the ingredient supplier Givaudan France Naturals, and two authors were employed by Givaudan [5].
The funding of the three earlier trials is not stated in their PubMed records [1][2][3]. All of this evidence is short-term and self-rated.
Does a single dose of lemon balm change thinking?
Results go in both directions, depending on dose and test [1][2]. In the 2002 trial, 600 mg improved accuracy of attention, while memory factors fell at certain doses and times [1]. In the 2003 trial, 1600 mg improved memory performance, but slower timed memory and poorer rapid visual information processing became more marked as the dose went down [2]. In the 2004 stress trial, 300 mg sped up mathematical processing with no loss of accuracy [3].
Food formats gave a similar mixed picture [4]. Two crossover studies, sponsored by Rudolf Wild GmbH & Co. KG and Cognis GmbH, which contributed to design discussions, gave lemon balm in a drink (25 participants) and a yogurt (21 participants) [4]. In the drink study, the 0.3 g dose with fruit sweetener was linked to lower state anxiety and better working memory at 1 and 3 hours, while the 0.6 g dose with artificial sweetener was linked to higher state anxiety at 3 hours [4]. The authors describe "costs" at some doses and effects that depended partly on the food used [4].
In the Givaudan-funded parallel trial of 106 stressed young adults, 300 mg improved performance on the hardest executive function trials at 5 hours [5]. That was not the primary outcome [5].
Does lemon balm affect mood over weeks?
The pooled evidence comes from people with symptoms, not from the general population [7]. A 2021 meta-analysis of randomized trials in patients with symptoms of anxiety or depression found lower anxiety scores (SMD -0.98; 95% CI -1.63 to -0.33) and depression scores (SMD -0.47; 95% CI -0.73 to -0.21) with lemon balm than with placebo [7]. SMD, a standardized mean difference, compares effects measured on different scales. The authors warned that heterogeneity between studies was high and that the number of trials was small [7].
In a 3-week trial of 100 healthy adults with moderate distress or poor sleep, 200 mg of the Relissa extract twice a day was followed by significant improvements in mood, anxiety, stress and wellbeing scores (all p values < 0.001) [8]. The extract and placebo tablets were donated by the ingredient supplier Indena S.p.A. [8].
Two trials in clinical populations also reported better scores [9][10]. In 44 people with type 2 diabetes and symptoms of depression who completed 12 weeks of 700 mg a day, depression and anxiety scores improved compared with a control [9]. In 80 people with chronic stable angina, 3 g a day for 8 weeks lowered depression, anxiety and stress scores compared with placebo [10]. Results in clinical groups may not apply to healthy adults.
Does lemon balm improve sleep quality?
Small, mostly industry-linked trials lean toward better sleep scores; one 12-week clinical trial found none [8][9][11]. In the 3-week Relissa trial (product donated by Indena), sleep scores on the Pittsburgh Sleep Quality Index improved more with the extract than with placebo, but the extract group started with significantly worse scores (p = 0.006) [8].
In a crossover trial of 30 adults who woke tired after unrefreshing sleep, 2 tablets of Melissa officinalis Phytosome (Meloff) each evening for 2 weeks lowered scores on the ISI, a sleep-difficulty questionnaire, to 6.8 ± 4.1, compared with 9.7 ± 3.7 on placebo (p = 0.003) [11]. In the same trial, 87% of participants reported better sleep on the extract, compared with 30% on placebo, and anxiety levels did not change [11]. The lead author is scientific director of Pharmextracta, which makes the product, and two authors consult for the company [11].
In the angina trial, total sleep disturbance fell with 3 g a day compared with placebo [10]. In the diabetes trial, sleep quality did not differ from the control after 12 weeks [9]. An open-label pilot of the Cyracos extract, supported by Naturex, found that clinician-rated sleep difficulty fell by 42% over 15 days in 20 stressed volunteers with mild-to-moderate anxiety and sleep disturbances [12]. Without a placebo group, it cannot separate the extract from other causes.
Does lemon balm affect overall cognition in older adults?
The largest trial found no effect on its primary outcome [13]. In 323 older adults with subjective or mild cognitive impairment who took an extract providing 500 mg of rosmarinic acid a day for 96 weeks, no cognitive measure differed from placebo [13]. In a subgroup analysis of participants without high blood pressure, scores on one clinical rating scale (CDR-SB) differed between groups (p = 0.036) [13].
A smaller, older trial in a clinical population reported a benefit [14]. In 42 people aged 65 to 80 with mild to moderate Alzheimer's disease, 60 drops a day of an extract for 4 months gave better scores on the ADAS-cog and CDR scales than placebo [14]. Results in clinical groups may not apply to healthy adults.
What the evidence does not show
The trials above do not show lasting effects of lemon balm on calmness or thinking in healthy adults: the Bond-Lader calmness and thinking trials in healthy adults tested single doses and measured effects over hours [1][2][3][5]; the one 3-week trial reported only within-group changes [8]. Evidence for combination products cannot be credited to lemon balm alone. In one crossover trial of 24 healthy volunteers, a lemon balm and valerian product lowered anxiety ratings at 600 mg, but raised them in one session at 1800 mg, and all three doses worsened Stroop task performance [6]. The European Medicines Agency based its conclusions on long-standing use and says clinical-trial evidence is insufficient but effectiveness is plausible [25].
Doses used in studies
Ranges researchers used, not dosing advice. Bars share one scale. Read our disclaimer.
0.3-0.6 g
Timing and form
In a pharmacokinetic study of 11 healthy individuals, serum rosmarinic acid peaked 1 hour after an extract containing 500 mg of rosmarinic acid taken fasting, with a maximum concentration of 162.20 nmol/L [15]. Food increased total exposure and delayed the peak [15]. In the single-dose calmness trials, effects were measured from 1 to 6 hours after dosing [1][2].
Forms studied include standardized extracts, encapsulated dried leaf, drinks, yogurt and tablets with a phospholipid carrier designed to improve absorption [1][2][3][4][8]. The Phytosome sleep trial gave the tablets 30 minutes before bed [11]. As of November 11, 2026 we found no trials comparing cycled with continuous use of lemon balm (PubMed search, November 11, 2026).
What it is
Lemon balm is the leaf of the plant Melissa officinalis L., which is cultivated or gathered for medicinal use, dried and powdered or cut, and used to make teas, extracts and tinctures [24][25]. It is also used as a vegetable and to flavor dishes [17], and the US lists "Balm (lemon balm)" among spices and natural flavorings generally recognized as safe for their intended use [20].
The leaf contains volatile compounds, triterpenoids, phenolic acids and flavonoids [17]. Its lemon-scented essential oil contains citronellal, neral and geranial, and its polyphenols include rosmarinic acid [23]. Health Canada lists bee balm, lemon balm and melissa as common names [26].
How it works (mechanism, not effect): reviewers propose acetylcholinesterase inhibition, stimulation of acetylcholine and GABA-A receptors, and inhibition of an enzyme called matrix metalloproteinase-2 as mechanisms [17]. In one crossover trial, the dried leaf used displaced nicotine and scopolamine from receptors in human brain tissue in the lab, but showed no cholinesterase inhibition [2].
Safety and interactions
What sources report. LiverTox gives lemon balm likelihood score E, an unlikely cause of clinically apparent liver injury, with only minor side effects in small trials [22]. The EU herbal monograph lists no known undesirable effects and contraindicates use with hypersensitivity to the herb [24]. EMA does not recommend use in pregnancy, lactation or children under 12 because of insufficient data [24]. EMA says lemon balm may impair the ability to drive and use machines, and Health Canada cautions about driving or using machinery because of possible drowsiness [24][26]. LactMed found no data on lemon balm in breastmilk or on its safety alone in nursing mothers or infants [23].
Who sources say should be careful.
- Pregnant or breastfeeding women. The European Medicines Agency says safety in pregnancy and lactation has not been established and use is not recommended [24]. Health Canada requires labels to tell people to ask a health care practitioner first [26]. LactMed found no data on lemon balm passing into breastmilk or on its safety alone in nursing mothers or infants [23].
- Children under 12. The EU monograph does not recommend use under 12 because adequate data are lacking [24].
- People who drive or operate machinery [24][26].
- People hypersensitive to lemon balm [24].
Trials and reviews report no serious side effects and only a few minor ones [7][22]. LiverTox says that in small trials, lemon balm extracts were linked to only a few minor, non-specific side effects (headache, dizziness, bloating), often at a similar rate to placebo [22]. LiverTox rates lemon balm with likelihood score E, an unlikely cause of clinically apparent liver injury, and found no published cases [22]. LactMed says nausea, vomiting, abdominal pain, dizziness and wheezing occur occasionally in adults [23].
The 2021 meta-analysis reported no serious side effects [7]. In the 3-week Relissa trial, no treatment-emergent or serious adverse events were reported [8]. In the pharmacokinetic study, a single dose did not affect liver, kidney or blood cell measures, and no adverse events were reported [15].
The European Medicines Agency's monograph lists undesirable effects as "None known" and says lemon balm may impair the ability to drive and use machines [24]. Health Canada requires a caution about driving or using machinery because of possible drowsiness [26]. The monograph lists hypersensitivity to the herb as a contraindication [24].
In laboratory and animal testing by researchers employed by Givaudan, which makes the extract tested, an aqueous extract was not genotoxic in cell and bacterial assays, and in a 90-day study in rats the no-observed-adverse-effect level was at least 3046.1 mg/kg body weight a day, the highest dose tested in males [16].
Interactions sources report
The European Medicines Agency's monograph says no interaction data are available [24]. As of November 11, 2026 we found no human study of interactions between lemon balm and any medicine (PubMed search, November 11, 2026). A 2016 review notes that data on interactions with standard medicines are still limited [17].
A 1985 laboratory paper reports earlier findings that freeze-dried lemon balm extract has antithyrotropic activity, meaning it binds thyroid-stimulating hormone (TSH) so that the hormone no longer binds well to its receptor [18]. This was a cell and tissue study, not a human trial, and its relevance to people taking lemon balm is unknown.
Health Canada and the European Medicines Agency also caution about driving or using machines (see Safety) [24][26]. These sources describe what has been reported, not what is right for any individual. If you take any medicines, including thyroid medicines, talk to your doctor or pharmacist before combining them with lemon balm.
Regulatory status
| Market | Status | Notes |
|---|---|---|
| US | Listed as Balm (lemon balm) among spices, natural flavorings, essential oils and natural extractives generally recognized as safe for their intended use (21 CFR 182.10 and 182.20). Under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed. | |
| UK | MHRA traditional herbal registration list dated October 29, 2026 includes lemon balm leaf capsules (THR 21710/0004) for the temporary relief of symptoms of mild anxiety, to aid sleep and for mild digestive complaints. Status as a food or food supplement: not verified as of November 11, 2026. We checked the MHRA traditional herbal registration list and could not confirm its status as a food. | |
| Canada | Health Canada monograph dated April 26, 2024: traditional herbal medicine claims for restlessness or nervousness and mild digestive disturbances, 0.4-13.5 g dried herb top per day, pregnancy, breastfeeding and drowsiness cautions. | |
| Australia | Melissa officinalis is a permissible ingredient (item 3252; active, excipient or homoeopathic) under the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026. | |
| EU | EU herbal monograph (EMA/HMPC/196745/2012, published 2013) covers melissa leaf as a traditional herbal medicinal product for mild symptoms of mental stress, to aid sleep and mild gastrointestinal complaints; periodic review under way (call for data 2024). Status as a food: not verified as of November 11, 2026. We checked the EMA melissa leaf pages, which cover medicines only, and could not confirm its status as a food. |
FAQ
Does lemon balm help with sleep?
Small trials lean that way [8][9][11]. Small trials in adults with poor sleep reported better sleep scores, including one with product donated by its supplier and one run by researchers working for the product's maker [8][11], while a 12-week trial in people with type 2 diabetes found no difference in sleep quality [9]. Regulators accept lemon balm "to aid sleep" on the basis of traditional use, not trial evidence [24][25][27].
Is lemon balm safe to take every day?
In a 96-week trial in older adults with subjective or mild cognitive impairment, vital signs and physical and neurological measures did not differ from placebo [13], and LiverTox rates lemon balm an unlikely cause of clinically apparent liver injury [22]. The European Medicines Agency does not recommend it in pregnancy, breastfeeding or for children under 12, and notes it may impair driving [24].
How much lemon balm did studies use?
Single-dose trials in healthy adults used 300 to 1600 mg [1][2][3], and longer trials used 400 mg a day in healthy adults with distress [8] up to 3 g a day in people with angina [10]. These are study doses, not advice.
Can lemon balm affect the thyroid?
A 1985 laboratory paper reports earlier findings that lemon balm extract bound thyroid-stimulating hormone and reduced its binding to the receptor [18]. As of November 11, 2026 we found no human study of interactions between lemon balm and thyroid or other medicines (PubMed search, 2026-11-11).
References
- Kennedy DO, Scholey AB, Tildesley NT, et al. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav. 2002.
- Kennedy DO, Wake G, Savelev S, et al. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology. 2003.
- Kennedy DO, Little W, Scholey AB. Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom Med. 2004.
- Scholey A, Gibbs A, Neale C, et al. Anti-stress effects of lemon balm-containing foods. Nutrients. 2014.
- Mathews I, Eastwood J, Bell L, et al. The acute effects of Zensera™ (Melissa officinalis L.) extract on mood and cognitive performance during cognitive overload: a randomised placebo-controlled, double-blind study in healthy young adults with moderate subjective stress. Ther Adv Psychopharmacol. 2026.
- Kennedy DO, Little W, Haskell CF, et al. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother Res. 2006.
- Ghazizadeh J, Sadigh-Eteghad S, Marx W, et al. The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta-analysis. Phytother Res. 2021.
- Bano A, Hepsomali P, Rabbani F, et al. The possible "calming effect" of subchronic supplementation of a standardised phospholipid carrier-based Melissa officinalis L. extract in healthy adults with emotional distress and poor sleep conditions: results from a prospective, randomised, double-blinded, placebo-controlled clinical trial. Front Pharmacol. 2023.
- Safari M, Asadi A, Aryaeian N, et al. The effects of melissa officinalis on depression and anxiety in type 2 diabetes patients with depression: a randomized double-blinded placebo-controlled clinical trial. BMC Complement Med Ther. 2023.
- Haybar H, Javid AZ, Haghighizadeh MH, et al. The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina. Clin Nutr ESPEN. 2018.
- Di Pierro F, Sisti D, Rocchi M, et al. Effects of Melissa officinalis Phytosome on Sleep Quality: Results of a Prospective, Double-Blind, Placebo-Controlled, and Cross-Over Study. Nutrients. 2024.
- Cases J, Ibarra A, Feuillère N, et al. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med J Nutrition Metab. 2011.
- Noguchi-Shinohara M, Hamaguchi T, Sakai K, et al. Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial. J Alzheimers Dis. 2023.
- Akhondzadeh S, Noroozian M, Mohammadi M, et al. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatry. 2003.
- Noguchi-Shinohara M, Ono K, Hamaguchi T, et al. Pharmacokinetics, Safety and Tolerability of Melissa officinalis Extract which Contained Rosmarinic Acid in Healthy Individuals: A Randomized Controlled Trial. PLoS One. 2015.
- Lobach AR, Schmidt F, Fedrizzi D, et al. Toxicological safety evaluation of an aqueous lemon balm (Melissa officinalis) extract. Food Chem Toxicol. 2024.
- Shakeri A, Sahebkar A, Javadi B. Melissa officinalis L. - A review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. 2016.
- Auf'mkolk M, Ingbar JC, Kubota K, et al. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins. Endocrinology. 1985.
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. Updated August 27, 2026.
- Electronic Code of Federal Regulations (US). 21 CFR 182.10 Spices and other natural seasonings and flavorings. Updated November 9, 2026.
- Electronic Code of Federal Regulations (US). 21 CFR 182.20 Essential oils, oleoresins (solvent-free), and natural extractives (including distillates). Updated November 9, 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIH), LiverTox. Lemon Balm (NBK600583, PMID 38381912). Updated February 10, 2024.
- National Institute of Child Health and Human Development (NIH), LactMed. Lemon Balm (NBK501841, PMID 30000901). Updated October 15, 2026.
- European Medicines Agency, Committee on Herbal Medicinal Products. Community herbal monograph on Melissa officinalis L., folium (Final, EMA/HMPC/196745/2012). Updated August 5, 2013.
- European Medicines Agency. Melissae folium - herbal medicinal product. Updated April 2, 2024.
- Health Canada, Natural and Non-prescription Health Products Directorate. Lemon Balm - Melissa officinalis (NHPID single ingredient monograph). Updated April 26, 2024.
- Medicines and Healthcare products Regulatory Agency (MHRA). Herbal medicines granted a traditional herbal registration (THR), list dated 29 October 2026. Updated October 29, 2026.
- Australian Government, Department of Health, Disability and Ageing (Federal Register of Legislation). Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026 (F2026L01382), volumes 1 and 4. Updated October 13, 2026.